Shilpa Medicare rallied 10.46% to Rs 503 after the company said it has entered into a three-year definitive agreement with Dr. Reddy s Laboratories for production and supply of the Sputnik V vaccine.In an exchange filing on Monday, Shilpa Medicare said that through its wholly owned subsidiary, Shilpa Biologicals, will produce and supply the Sputnik V vaccine from its integrated biologics R&D cum manufacturing center at Dharwad, Karnataka.
The targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses (50 million of Component 1 and 50 million of component 2), from the date of start of commercial production.
Dr. Reddy s has partnered with HV/RDIF for clinical development of the vaccine and has distribution rights in geographies including India. Dr. Reddy s will facilitate the transfer of the sputnik technology to Shilpa Biologicals. Under the agreement, Shilpa Biologicals will be responsible for manufacture of the vaccine, while DRL is responsible fo
Sugar and Confectionery Product Manufacturing Industry | Discover, Track, Compare, Evaluate Companies on BizVibe
BizVibe is continuing to expand the number of companies which can be discovered and tracked within their sugar and confectionery product manufacturing category offering. Users can browse unlimited company profiles, allowing them to discover 10,000+ sugar and confectionery product manufacturing companies, spanning across 100+ countries, which are categorized into 100+ product and services.
Discover Companies for Free
Snapshot of BizVibe s sugar and confectionery product manufacturing category (Graphic: Business Wire)
Companies listed under sugar and confectionery product manufacturing are defined as being primarily engaged in processing agricultural inputs, such as sugarcane, beet, and cacao. BizVibe s detailed company profile insights help users to discover, track, evaluate, and connect with sugar and confectionery product manufacturing companies from all over the wor